Skip to main content
. 2011 Sep 15;204(6):854–863. doi: 10.1093/infdis/jir440

Table 4.

Geometric Mean Hemagglutination Inhibition and Microneutralization Titers to the 2009 H1N1 Influenza Vaccine According to Prior Receipt of 2008–2009 and/or 2009–2010 Seasonal Influenza Vaccines

Assay Dose group Received 2008–2009 and/or 2009–2010 seasonal influenza vaccine No. of subjects Day 0, GMT (95% CI) No. of subjects Day 21 after dose 1, GMT (95% CI) No. of subjects Day 21 after dose 2, GMT (95% CI)
HAI 25 μg No 10 5.2 (4.8–5.6) 10 355.1 (142.5–884.9) 8 349.0 (123.8–983.4)
Yes 44 7.2 (5.3–9.8) 44 380.5 (240.8–601.4) 29 347.9 (196.1–617.2)
49 μg No 17 5.8 (4.3–7.8) 17 417.1 (225.3–772.1) 14 430.7 (264.0–702.5)
Yes 40 6.7 (5.0–8.9) 40 489.3 (312.8–765.2) 36 320.0 (186.2–549.9)
MN 25 μg No 10 5.0 (…)1 10 320.0 (129.4–791.2) 8 293.4 (106.6–807.8)
Yes 44 11.0 (8.0–15.0) 44 467.0 (309.1–705.6) 29 574.7 (376.5–877.3)
49 μg No 17 6.8 (4.5–10.3) 17 461.9 (257.1–829.7) 14 551.7 (320.8–948.7)
Yes 40 11.3 (8.3–15.4) 40 662.6 (462.2–949.8) 36 543.4 (385.3–766.4)

NOTE. CI, confidence interval.

1

All samples had the same value (below the limit of detection of a titer of 1:10), and therefore confidence intervals could not be calculated.